Using wearables and a phone app to find early signs of prediabetes

GLOW UP: A Single-Center Observational Study Developing Digital Biomarkers for Prediabetes Screening and Lifestyle Phenotyping

Observational University of St.Gallen · NCT07373418

This project will try to see if data from wearable devices and a meal‑logging smartphone app can distinguish adults 45+ with BMI ≥25 who have prediabetes from those with normal blood sugar.

Quick facts

Study typeObservational
Enrollment200 (estimated)
Ages45 Years and up
SexAll
SponsorUniversity of St.Gallen Academic / other
Locations1 site (Sankt Gallen)
Trial IDNCT07373418 on ClinicalTrials.gov

What this trial studies

The GLOW UP project is a single-center, prospective observational case-control study in St. Gallen, Switzerland enrolling 200 adults aged 45 and older with BMI ≥25, including 100 with prediabetes and 100 normoglycemic controls. Participants will wear consumer wearable devices and use a smartphone app with image-based meal logging for about four weeks while clinical blood tests classify glycemic status. Researchers will analyze lifestyle and glycemic patterns, including between- and within-person variability, to identify personalized predictors of early metabolic dysregulation and will test how reminder messages affect meal logging adherence. The study emphasizes real-world data from wearables and apps to explore noninvasive signals linked to diabetes risk.

Who should consider this trial

Good fit: Ideal candidates are German-speaking Swiss residents aged 45 or older with BMI ≥25, no known diabetes, regular access to and ability to use a smartphone, and able to walk independently.

Not a fit: People with diagnosed diabetes, major cardiovascular or kidney disease, pregnant or breastfeeding individuals, those with skin conditions preventing wearable use, or those without a compatible smartphone or living outside the St. Gallen area are unlikely to benefit.

Why it matters

Potential benefit: If successful, this approach could enable earlier, easier detection of metabolic changes using everyday wearables and apps so people can take steps to lower their diabetes risk.

How similar studies have performed: Previous research has shown wearables can capture activity and sleep patterns related to glucose, but using image-based meal logging and personalized wearable signatures to detect prediabetes is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Citizens or residents of Switzerland who are German-speaking (main place of living or employment in Switzerland).
* Age ≥45 years.
* BMI ≥25 kg/m² (overweight or obese).
* Regular access to a smartphone (iOS or Android) with a data plan.
* Able to use smartphone applications.
* Able to walk independently.

Exclusion Criteria:

* History of stroke, heart disease, renal failure, cancer, or diabetes (type 1 or type 2).
* Past vascular bypass surgery or angioplasty.
* Current or planned use of glucose-lowering medications during the upcoming 4 weeks (e.g., GLP-1 receptor agonists, metformin).
* Pregnant or breastfeeding.
* Relevant skin conditions at wearable placement sites (e.g., upper arm).
* BMI \<25 kg/m² confirmed at enrollment.
* FPG ≥7.0 mmol/L and/or HbA1c ≥6.5% (newly identified type 2 diabetes); Individuals who meet type-2 diabetes criteria at enrollment, based on Swiss/ADA diagnostic criteria will be informed of blood test results and referred to a GP. These individuals will be deemed ineligible and excluded from the study.

Where this trial is running

Sankt Gallen

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Prevention
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.